Created in 1964, Inserm is a public institution with a scientific and technical vocation, under the dual auspices of the Ministry of Health and the Ministry of Higher Education and Research. Inserm iis the only French public research body entirely dedicated to human health. Its researchers are committed to studying all diseases, whether common or rare, through their research in the fields of biology, medicine and public health.
Two Inserm laboratories will be involved in NEUROBID: UMR-842 neuro-oncology / neuroinflammatory diseases and UMR-676 perinatal brain damage. The main objective of these teams is to establish the roles of blood-brain barriers in the pathophysiology and pharmacology of CNS diseases as well as to design neuroprotective strategies.
Within the present project, the UMR-842 is more specifically in charge of the investigations on neuroprotective functions of the blood-CSF barrier in health and diseases and related drug targeting strategies during brain development, while UMR-676 will focus on providing relevant models for perinatal and adult brain damage as well as testing protective drugs.